Antibacterial agents: New routes to tuberculosis treatment

Nature Reviews Drug Discovery 16, 600 (2017). doi:10.1038/nrd.2017.156 Author: Sarah Crunkhorn Treatment of drug-resistant strains of Mycobacterium tuberculosis is lengthy, involving the use of costly and less effective second-line drugs that exhibit substantial side effects. Two new papers now report the identification of novel agents that inhibit previously untargeted essential M. tuberculosis enzymes and
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Research Highlight Source Type: research